MENU

CALT Calliditas Therapeutics AB Forecast, Technical & Fundamental Analysis

a provider of pharmaceutical products for patients with niche indications

Industry Biotechnology
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published Earnings

CALT is expected to report earnings to fall 148.48% to 8 cents per share on November 11

Calliditas Therapeutics AB CALT Stock Earnings Reports
Q3'24
Est.
$0.08
Q2'24
Missed
by $0.06
Q1'24
Missed
by $0.66
Q4'23
Beat
by $0.12
Q3'23
Beat
by $0.10
The last earnings report on August 13 showed earnings per share of -16 cents, missing the estimate of -10 cents. With 9.80K shares outstanding, the current market capitalization sits at 1.10B.
A.I. Advisor
published General Information

General Information

a provider of pharmaceutical products for patients with niche indications

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Kungsbron 1, D5
Phone
+46 84113005
Employees
86
Web
https://www.calliditas.se
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

CALT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CALT has been loosely correlated with INSM. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if CALT jumps, then INSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CALT
1D Price
Change %
CALT100%
+3.56%
INSM - CALT
64%
Loosely correlated
-4.14%
THAR - CALT
52%
Loosely correlated
+4.78%
AGIO - CALT
30%
Poorly correlated
-2.57%
ARCT - CALT
29%
Poorly correlated
-8.10%
BGNE - CALT
25%
Poorly correlated
-1.84%
More

Groups containing CALT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CALT
1D Price
Change %
CALT100%
+3.56%
pharmaceutical
theme (4 stocks)
65%
Loosely correlated
-0.20%
treatment
theme (61 stocks)
8%
Poorly correlated
+0.91%
therapeutics
theme (57 stocks)
7%
Poorly correlated
+20.54%